GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lytix Biopharma AS LYTIX.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

8.38

+6.08%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Lytix Biopharma AS annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In NOK.

FY2025FY2024FY2023FY2022FY2021
Revenue—NOK 11.1mNOK 4.0mNOK 1.4mNOK 17,000
Operating income−NOK 64.0m−NOK 95.9m−NOK 96.8m−NOK 65.7m−NOK 48.0m
Net income−NOK 60.0m−NOK 94.3m−NOK 87.9m−NOK 56.0m−NOK 48.0m
Free cash flow−NOK 59.9m−NOK 70.4m−NOK 96.0m−NOK 52.3m−NOK 45.1m
Total assetsNOK 81.5mNOK 146.5mNOK 63.9mNOK 152.0mNOK 203.0m
Shareholders' equityNOK 61.8mNOK 107.9mNOK 51.3mNOK 135.1mNOK 189.6m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.